These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 719903)

  • 1. Excretion of cis- and trans-4-hydroxycyclohexylacetic acid in addition to hawkinsin in a family with a postulated defect of 4-hydroxyphenylpyruvate dioxygenase.
    Niederwieser A; Wadman SK; Danks DM
    Clin Chim Acta; 1978 Dec; 90(2):195-200. PubMed ID: 719903
    [No Abstract]   [Full Text] [Related]  

  • 2. A new sulfur amino acid, named hawkinsin, identified in a baby with transient tyrosinemia and her mother.
    Niederwieser A; Matasovic A; Tippett P; Danks DM
    Clin Chim Acta; 1977 May; 76(3):345-56. PubMed ID: 858207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tyrosine metabolites in humans: hawkinsin and cis- and trans-4-hydroxycyclohexylacetic acids. Unusual adsorption of deuterated and non-deuterated hawkinsin during gas chromatography.
    Niederwieser A; Matasović A; Neuheiser F; Wetzel E
    J Chromatogr; 1978 Sep; 146(2):207-12. PubMed ID: 701419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hawkinsinuria--identification of quinolacetic acid and pyroglutamic acid during an acidotic phase.
    Hocart CH; Halpern B; Hick LA; Wong CO
    J Chromatogr; 1983 Jul; 275(2):237-43. PubMed ID: 6619234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow up of a new case of hawkinsinuria.
    Lehnert W; Stögmann W; Engelke U; Wevers RA; van den Berg GB
    Eur J Pediatr; 1999 Jul; 158(7):578-82. PubMed ID: 10412819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.
    Giardini O; Cantani A; Kennaway NG; D'Eufemia P
    Pediatr Res; 1983 Jan; 17(1):25-9. PubMed ID: 6132360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
    Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
    Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
    [No Abstract]   [Full Text] [Related]  

  • 8. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract]   [Full Text] [Related]  

  • 9. Hawkinsinuria: a dominantly inherited defect of tyrosine metabolism with severe effects in infancy.
    Wilcken B; Hammond JW; Howard N; Bohane T; Hocart C; Halpern B
    N Engl J Med; 1981 Oct; 305(15):865-8. PubMed ID: 7278885
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
    Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
    Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association, in the same subject, of deletion of the short arm of chromosome 4 (4p-) and of complete deficiency of parahydroxyphenyl-pyruvate oxidase activity in the liver (tyrosinosis)].
    Malpuech G; Mattei JF; Gaulme J; Palcoux JB; Lesec G; Vanlieferinghen P
    J Genet Hum; 1981 Dec; 29(4):455-61. PubMed ID: 7328420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary p-tyramine in hereditary tyrosinemia: II. Origin of urinary p-tyramine.
    Hoag GN; Hill A; Zaleski W
    Clin Biochem; 1977 Feb; 10(1):26-8. PubMed ID: 837523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary p-tyramine in hereditary tyrosinemia: I. Levels as compared to normal individuals, effect of diet, and relationship to urinary tyrosine.
    Hoag GN; Hill A; Zaleski W
    Clin Biochem; 1977 Feb; 10(1):24-5. PubMed ID: 837522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K; Matolon R; Wong PW
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hawkinsinuria in two families.
    Borden M; Holm J; Leslie J; Sweetman L; Nyhan WL; Fleisher L; Nadler H; Lewis D; Scott CR
    Am J Med Genet; 1992 Sep; 44(1):52-6. PubMed ID: 1519651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
    Item CB; Mihalek I; Lichtarge O; Jalan A; Vodopiutz J; Muhl A; Bodamer OA
    Mol Genet Metab; 2007 Aug; 91(4):379-83. PubMed ID: 17560158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tyrosine aminotransferase and para-hydroxyphenylpyruvate dioxygenase activities in fetal and neonatal human liver.
    Ohisalo JJ; Laskowska-Klita T; Andersson SM
    J Clin Invest; 1982 Jul; 70(1):198-200. PubMed ID: 6123525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate substrates and inhibitors of bacterial 4-hydroxyphenylpyruvate dioxygenase.
    Pascal RA; Oliver MA; Chen YC
    Biochemistry; 1985 Jun; 24(13):3158-65. PubMed ID: 4027238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.